Ithaka Group’s Amgen AMGN Stock Holding History

Ithaka Group’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,000	Closed	-$254K	–	37
2020 Q3	$254K	Hold	1,000	–	–	0.03%	36
2020 Q2	$236K	Hold	1,000	–	–	0.03%	37
2020 Q1	$203K	Hold	1,000	–	–	0.04%	37
2019 Q4	$241K	Buy	+1,000	New	+$220K	0.04%	36
2018 Q4	–	Sell	-1,000	Closed	-$207K	–	39
2018 Q3	$207K	Buy	+1,000	New	+$197K	0.03%	39

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ithaka Group's AMGN Position: Q4 2020 in Review

Ithaka Group sold out of Amgen (AMGN) in Q4 2020, closing a stake of 1,000 shares — an estimated $254K sold.

Ithaka Group first reported a position in AMGN in Q3 2018 and held it in 5 quarters. The position peaked at $254K in Q3 2020. 2,218 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

Ithaka Group reported no remaining Amgen position as of Q4 2020 after selling out during the quarter.
Ithaka Group sold 1,000 Amgen shares in Q4 2020, an estimated $254K.
Ithaka Group first reported a position in Amgen in Q3 2018 and held it in 5 quarters.
Ithaka Group's Amgen position peaked at $254K in Q3 2020.
2,218 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Ithaka Group's 13F filing for Q4 2020, filed 8 Feb 2021.